Cancer Survival And Symptom Trials May Be "Ideal Drug Package" - Pazdur
Executive Summary
Submission of one cancer survival trial and one symptom trial for approval of oncologic agents would be considered optimal by FDA, Oncologic Drug Products Division Director Richard Pazdur, MD, said.